Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000927016-03-001791
Filing Date
2003-04-11
Accepted
2003-04-11 16:27:12
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K DATED 12/31/2002 d10k.htm 10-K 1294043
3 AGREEMENT AND PLAN OF REORGANIZATION dex101.txt EX-10.1 99468
4 DEVELOPMENT SUPPLY AGREEMENT DATED 12/18/02 dex102.txt EX-10.2 61929
5 SUBSIDIARIES dex21.htm EX-21 2630
6 CONSENT - DELOITTE & TOUCHE LLP dex231.htm EX-23.1 2200
7 CONSENT - DELOITTE & TOUCHE LLP dex232.htm EX-23.2 2229
8 CERTIFICATION dex991.htm EX-99.1 5100
9 GRAPHIC g43646g57v08.jpg GRAPHIC 91158
  Complete submission text file 0000927016-03-001791.txt   1561430
Mailing Address 31 ST JAMES AVE 8TH FL BOSTON MA 02116
Business Address 31 ST. JAMES AVENUE 8TH FLOOR BOSTON MA 02116 6174220674
GLYCOGENESYS INC (Filer) CIK: 0000946661 (see all company filings)

EIN.: 330231238 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26476 | Film No.: 03647321
SIC: 2836 Biological Products, (No Diagnostic Substances)